サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1138376

ヘルニア修復デバイスの世界市場-2022-2029

Global Hernia Repair Devices Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
ヘルニア修復デバイスの世界市場-2022-2029
出版日: 2022年10月18日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場力学

ヘルニア修復デバイスの開発に対する資金調達と投資の増加が、市場成長の原動力になると予想されます。

複数の企業が、ヘルニア修復デバイスの開発のための資金調達や投資を行っています。例えば、2020年1月、Virtual Incision Corporationは、投資家のBluestem Capitalが主導し、復帰投資家のPrairieGold Venture PartnersとGenesis Innovation Groupおよびその他の関連投資家が参加するシリーズB+資金調達ラウンドで2000万米ドルを調達しました。この資金は、ヘルニア修復、胆嚢摘出、逆流防止手術、脾臓摘出、副腎摘出、ガストリックスリーブ、ガストリックバイパス、子宮摘出、肝・膵・胆道処置など様々な用途に対応する小型生体ロボットアシスタント（MIRA）外科用ロボットプラットフォームの商業化につながる規制および臨床プログラムのサポートに使われる予定だそうです。したがって、上記の記述から、予測期間において市場を牽引することが期待されます。

ヘルニア修復デバイスの使用に伴う副作用が市場成長の妨げになると予想されます。

市場は、ヘルニア修復デバイスの使用に関連する副作用によって阻害されます。ヘルニア修復デバイスで治療した患者の間で、痛み、感染、再発、癒着、腸閉塞、臓器穿孔など、いくつかの副作用が観察されています。British Journal of Surgeryによると、ヘルニアメッシュのコーティングにより、1週間は癒着が抑えられました。1ヶ月後にはヘルニアメッシュコーティングによる癒着防止は見られませんでした。また、メッシュは体内を移動するため、腸閉塞につながります。食品医薬品局（FDA）によると、回収されたメッシュは、患者の腸の前庭形成や閉塞の主な原因となっています。また、炎症、発熱、その他インフルエンザのような症状などの慢性的な感染症が観察されるとのことです。米国食品医薬品局（FDA）によると、エチコン社製フィジオメッシュ・インプラントは、患者の間で剥離・移動していました。このインプラントは、患者の腸と皮膚に付着していました。このインプラントの移動により、過剰な痛みと深刻なダメージが発生しました。

COVID-19の影響分析

ヘルニア修復デバイスの世界市場は、COVID-19の大流行による影響を受けています。COVID-19に感染した患者の増加に伴い、ヘルニア修復手術を受ける患者の数が減少しているからです。COVID-19は、角膜手術の実施に深刻な脅威となる可能性があります。世界的にヘルニア修復デバイスの需要は、ヘルニア修復手術を受ける人の減少に伴い、COVID-19の流行によって減少しています。F. Kockerling et.al. 2020によると、COVID-19による混乱のピーク時の12週間で、約2800万件の待機手術がキャンセルされました。ヘルニア登録によると、鼠径ヘルニア修復術は、COVID-19の流行により、2020年2月の6699件から2020年6月には3033件に減少していることがわかっています。臍ヘルニア修復術は、2020年2月の1,692件から2020年6月の1,421件に減少しています。

産業分析

ヘルニア修復デバイス市場は、アンメットニーズ、価格分析、サプライチェーン分析、規制分析など、様々な産業要因に基づく市場の詳細な分析を提供します。

世界のヘルニア修復デバイス市場レポートでは、約45+市場データ表、40+図、180ページの構成で提供しています。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

  • 製品タイプ別市場内訳
  • ヘルニアタイプ別市場内訳
  • 市場内訳：治療分野別
  • 治療タイプ別市場内訳
  • DataM CLOシナリオ

第4章 力学

  • 市場影響要因
  • 促進要因
    • ヘルニア修復手術におけるメッシュの採用の増加
    • 新製品の開発
  • 抑制要因
    • メッシュの高コスト
    • 製品不良のリスク
  • ビジネスチャンス
  • 影響分析

第5章 ヘルニア修復デバイスの産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格設定分析
  • 規制分析
  • 特許分析

第6章 製品タイプ別

  • メッシュ＆パッチ
    • 天然素材
    • 合成
  • 内視鏡機器
    • 心電計
    • レントゲン
    • その他
  • 外科用機器
    • 縫合糸
    • グラッパー
    • ハサミ
    • ニードル促進要因
    • その他
  • その他
    • インプラント
    • アクセス＆ディスセクションデバイス
    • イリゲーションアクセサリー

第7章 ヘルニアタイプ別

  • 鼠径ヘルニア
    • 直接鼠径ヘルニア
    • 間接的鼠径ヘルニア
  • 裂孔ヘルニア
  • 臍帯ヘルニア
  • 切開ヘルニア
  • 大腿ヘルニア
  • 脊髄性ヘルニア
  • 脇腹/腰椎ヘルニア
  • 上腹部ヘルニア

第8章 治療部位タイプ別

  • 腹部
    • 直接鼠径ヘルニア
    • 間接的鼠径ヘルニア
  • 大腿上部
  • 腹部
  • 鼠径部

第9章 治療法別

  • 腹腔鏡下手術
    • 直接鼠径ヘルニア
    • 間接的鼠径ヘルニア
  • オープンテンションリペア
  • 非緊迫性修復術
  • ロボット手術
  • 腹壁再建術

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東とアフリカ

第11章 競合情勢

第12章 競合情勢

  • 競合シナリオ
  • 競合他社の戦略分析
  • 製品ポートフォリオ比較分析
  • 市況/シェア分析
  • M&A（合併・買収）分析

第13章 企業プロファイル

  • Medtroinc Plc
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • B. Braun Melsungen AG
  • Cook Inc.
  • C.R. Bard
  • Integra Lifesciences Holdings Corporation
  • Baxter International Inc.
  • Cooper Surgical Inc.
  • Lifecell Corporation
  • Stryker Corporation
  • Atrium Medical Corporation

第14章 DataM

目次
Product Code: DMMD1249

Market Overview

Hernia Repair Devices Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.65% during the forecast period (2022-2029).

Hernia is the condition in which the internal organ or fatty tissue surges out through the fascia, a weak spot present in a surrounding muscle or connective tissue. A hernia occurs most frequently within the abdominal cavity, between the chest and the hips. Inguinal hernia, femoral hernia, umbilical hernia, hiatal hernia, and others are the most prevalent hernia observed across the globe. A hernia is characterized by the signs and symptoms such as swelling in the groin or scrotum, pain at the site of the bulge, pain while lifting, increased bulge size over time, aching sensation, and bowel obstruction.

Hernia repair devices are the devices that are used for performing the surgical procedure for the correction of hernia. Hernia repair devices are used for performing laparoscopic and open repair surgery. The market is dominated by the availability of hernia mesh, including synthetic mesh & biologic mesh, and mesh fixators, including the sutures, tack applicators, and glue applicators.

Market Dynamics

Increasing funding & investment for the development of the Hernia Repair Devices is expected to drive market growth.

Several companies are raising the funding and investment for developing the Hernia Repair Devices. For instance, in January 2020, Virtual Incision Corporation raised USD 20 million in a Series B+ financing round led by the investor Bluestem Capital, with participation from returning investor PrairieGold Venture Partners and Genesis Innovation Group and other affiliated investors. This funding would be used to support the regulatory and clinical programs leading to the commercialization of the miniaturized in vivo robotic assistant (MIRA) Surgical Robotic Platform for various applications such as hernia repair, gallbladder removal, anti-reflux surgery, splenectomy, adrenalectomy, gastric sleeve, gastric bypass, hysterectomy, and hepato-pancreato-biliary procedures. Thus, from the above statements, the market is expected to drive in the forecast period.

Adverse Effects Associated with using Hernia Repair Devices are expected to hamper the market growth.

The market is hindered by the adverse effects associated with the use of hernia repair devices. Several adverse effects were observed among patients treated with hernia repair devices, such as pain, infection, recurrence, adhesion, bowel obstruction, organ perforation, and other adverse effects. According to the British Journal of Surgery, the hernia mesh's coating has reduced the adhesion for a week. There was no adhesion prevention through the hernia mesh coating after a month. Mesh also leads to bowel obstruction as it can migrate in the body. According to the Food and Drug Administration (FDA), the recalled mesh is the leading cause of bowel preformation and obstruction among patients. Chronic infections such as inflammation, fever, and other flu-like symptoms are observed among the patients. According to the Food and Drug Administration (FDA), the Ethicon physiomesh implant was detached and migrated among the patients. This implant was attached to the patient's intestine and the skin. Migration of the implant resulted in excess pain and severe damage.

COVID-19 Impact Analysis

The global hernia repair devices market has been impacted due to the COVID-19 pandemic as there is decreased number of the patients undergoing the hernia repair surgeries with the increasing number of people suffering from the COVID-19. The COVID-19 can be a serious threat for carrying out the corneal surgery. Globally, the demand of the hernia repair devices has reduced due to COVID-19 pandemic with the decrease in the number of the people undergoing the hernia repair surgery. According to the F. Kockerling et.al. 2020, approximately, 28 million elective operations were cancelled during the peak 12 weeks of disruption occurred due to COVID-19. According to the hernia registry, the number of inguinal hernia repair surgery had witnessed the decreased from the 6,699 surgeries in February 2020 to 3033 in June 2020 due to COVID-19 pandemic. The number of the umbilical hernia repair surgeries has decreased from 1, 692 in February 2020 to 1,421 in June 2020.

Industry Analysis

The hernia repair devices market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis

The hernia mesh segment is expected to hold the largest share in the hernia repair devices market.

The hernia mesh segment accounted for holding the largest share in the hernia repair devices market due to the rising penetration of the hernia mesh. As per Sanders DL et al., yearly, around 20 million prosthetic meshes are implanted among patients with hernias worldwide. Every year nine out of ten hernia surgeries are performed using the hernia mesh in the United States. Hernia mesh supports the damaged tissue around hernias. It can be easily placed around the hernia by attaching it with stitches, staples, or glue. Hernia mesh comprises synthetic materials that can be absorbable, non-absorbable or a combination of both materials found in knitted mesh or non-knitted sheet forms. Hernia mesh is effective in lowering the recurrence of the hernias. The market is dominated by the availability of several hernia mesh products. For instance, Atrium comprises the several hernia mesh product portfolio such as C-QUR, Vitamesh, Proloop, Prolite, and Prolite UltraQ; B. Braun comprises the several hernia mesh portfolio such as Premilene, Omyra, Optilene; LifeCell Corporation comprises the hernia mesh product portfolio such as Alloderm Select, Strattice; and Medtronic comprised of the hernia mesh product portfolio such as Parietex, Permacol, ProGrip, Symbotex, Versatex.

Geographical Analysis

North American region is expected to hold the largest market share in the global hernia repair devices market.

North America dominated the global hernia repair devices market. It accounted for the largest market share in 2021, owing to the increasing adoption of hernia repair devices for performing hernia repair surgeries. According to Raquel Maia et al. 2021, published in Annals of Laparoscopic and Endoscopic Surgery, around 350,000 abdominal wall hernia repair surgeries were performed in a year. There is a high recurrence rate of hernias. The United States accounts for the highest market share due to the availability of favorable reimbursement policies for hernia repair surgeries. There is the presence of several market players developing advanced hernia repair devices. For instance, Ariste Medical gained 510(k) authorization from the US Food and Drug Administration in April 2022 to market their drug-embedded, synthetic hernia mesh in the US.

Competitive Landscape

Major key players in the hernia repair devices market are Medtronic Plc, Ethicon Inc., Atrium, Lifecell Corporation, B Braun Melsungen AG, Baxter International, Inc., Cook Medical, Becton, Dickinson and Company, CooperSurgical Inc., Insightra Medical, Inc., Olympus Corporation, and Integra Lifesciences.

Medtronic Plc:

Overview:

Medtronic plc is an American-Irish registered medical device company primarily operating in the United States. It has an operational and executive headquarters in Fridley, Minnesota, in the US. Moreover, it develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders and diabetes. It is operated in 140 countries and employs over 104,950 people.

Product Portfolio:

Dextile Anatomical Mesh: Dextile anatomical mesh offers:

  • 3-D patented anatomical shape conforms with each side of the inguinal anatomy contours.
  • Wide coverage of the myopectineal orifice to minimize the risk of recurrence.
  • Exclusive structure to maintain shape after trocar passage.
  • Large pore size supports excellent tissue ingrowth and visualization of surrounding anatomy during surgery.

The global hernia repair devices market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Product type
  • 3.2. Market Snippet By Hernia type
  • 3.3. Market Snippet By Therapeutic area type
  • 3.4. Market Snippet By Treatment type
  • 3.5. DataM CLO Scenario

4. Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. Increasing adoption of mesh in hernia repair surgeries
    • 4.2.2. New product developments.
  • 4.3. Restraints
    • 4.3.1. High cost of meshes
    • 4.3.2. Risk of product failures
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Hernia Repair Devices Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Patent Analysis

6. By Product type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type Segment
    • 6.1.2. Market Attractiveness Index, By Product type Segment
  • 6.2. Mesh & Patch
    • 6.2.1. Introduction
      • 6.2.1.1. Natural
      • 6.2.1.2. Synthetic
    • 6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 6.3. Endoscopy Instruments
    • 6.3.1. Electrocardiogram
    • 6.3.2. X-ray
    • 6.3.3. Others
  • 6.4. Surgical Instruments
    • 6.4.1. Sutures
    • 6.4.2. Graspers
    • 6.4.3. Scissors
    • 6.4.4. Needle drivers
    • 6.4.5. Others
  • 6.5. Others
    • 6.5.1. Implants
    • 6.5.2. Access and Dissection devices
    • 6.5.3. Irrigation accessories

7. By Hernia type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type Segment
    • 7.1.2. Market Attractiveness Index, By Hernia type Segment
  • 7.2. Inguinal hernia
    • 7.2.1. Introduction
      • 7.2.1.1. Direct Inguinal hernia
      • 7.2.1.2. Indirect Inguinal hernia
    • 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 7.3. Hiatal hernia
  • 7.4. Umbilical hernia
  • 7.5. Incisional hernia
  • 7.6. Femoral Hernia
  • 7.7. Spigelian Hernia
  • 7.8. Flank/Lumbar Hernia
  • 7.9. Epigastric Hernia

8. By Therapeutic area type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area Segment
    • 8.1.2. Market Attractiveness Index, By Therapeutic area Segment
  • 8.2. Abdomen
    • 8.2.1. Introduction
      • 8.2.1.1. Direct Inguinal hernia
      • 8.2.1.2. Indirect Inguinal hernia
    • 8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 8.3. Upper Thigh
  • 8.4. Belly button
  • 8.5. Groin

9. By Treatment

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Segment
    • 9.1.2. Market Attractiveness Index, By Treatment Segment
  • 9.2. Laparoscopic Surgery
    • 9.2.1. Introduction
      • 9.2.1.1. Direct Inguinal hernia
      • 9.2.1.2. Indirect Inguinal hernia
    • 9.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 9.3. Open Tension Repair
  • 9.4. Non Tension Repair
  • 9.5. Robotic Repair
  • 9.6. Abdominal Wall Reconstruction

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.2.7.1. The U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. Australia
      • 10.5.7.5. Rest of Asia Pacific
  • 10.6. The Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment

11. Competitive Landscape

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Competitor Strategy Analysis
  • 12.3. Comparative Product Portfolio Analysis
  • 12.4. Market Positioning/Share Analysis
  • 12.5. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Medtroinc Plc
    • 13.1.1. Company overview
    • 13.1.2. Product portfolio and description
    • 13.1.3. Key highlights
    • 13.1.4. Financial overview
  • 13.2. B. Braun Melsungen AG
  • 13.3. Cook Inc.
  • 13.4. C.R. Bard
  • 13.5. Integra Lifesciences Holdings Corporation
  • 13.6. Baxter International Inc.
  • 13.7. Cooper Surgical Inc.
  • 13.8. Lifecell Corporation
  • 13.9. Stryker Corporation
  • 13.10. Atrium Medical Corporation

14. DataM Intelligence

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us